Anna Björkenheim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Björkenheim has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Anders Magnuson
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, SE 70182 Örebro, Sweden
4 shared publicationsNils Edvardsson
Sahlgrenska Academy at Sahlgrenska University Hospital
4 shared publicationsAlexander Chemnitz
Department of Cardiology, Odense University Hospital, Odense, Denmark
3 shared publications- Axel Brandes
Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark , Finsensgade 35, Esbjerg 6700
3 shared publications - Dritan Poci
School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
3 shared publications Dritan Poçi
Department of Cardiology, School of Medical Sciences, Örebro University, Örebro, Sweden
3 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1) , 804
Bone morphogenetic protein 10 and one-year outcomes after open revascularisation in symptomatic peripheral arterial disease or carotid stenosis
Background: Bone morphogenetic protein 10 (BMP10) has atrial-specific and vascular properties and may reflect both atrial and vascular pathophysiology. We investigated whether BMP10 levels were associated with new-onset atrial fibrillation (AF), major adverse cardiovascular events (MACE), and all-cause mortality after open revascularisation for symptomatic peripheral arterial disease (PAD) or carotid stenosis (CS). Methods: Patients scheduled for endarterectomy for symptomatic PAD or CS were enrolled. BMP10 concentrations were measured using a multiplex immunoassay. Clinical outcomes were obtained from medical records during one-year follow-up. Associations between BMP10 and outcomes were assessed using Cox proportional hazards regression. Results: A total of 210 patients were included (63% men; 61% underwent surgery for PAD). Women were older than men and had higher BMP10 levels. Forty patients had known preoperative AF. During one-year follow-up, 26 patients experienced MACE and 13 died. Among 170 patients without AF at baseline, 10 developed new-onset AF. In unadjusted Cox regression, higher BMP10 levels were associated with MACE (HR 1.01, 95% CI 1.00-1.03; p = 0.047) and all-cause mortality (HR 1.03, 95% CI 1.01–1.04; p < 0.001), but not with new-onset AF (HR 1.00, 95% CI 0.97–1.03; p = 0.80). Effect estimates were similar after adjustment for age and sex. Model-based point estimates of one-year cumulative incidence were numerically higher at higher BMP10 concentrations for MACE and all-cause mortality, although confidence intervals were wide; no corresponding pattern was observed for new-onset AF. Conclusions: In this exploratory cohort, higher BMP10 levels were associated with MACE and all-cause mortality after endarterectomy for symptomatic PAD or CS. Women had higher BMP10 levels than men. These findings should be interpreted cautiously and considered hypothesis-generating; larger studies are required to validate the observed associations.
- 16 September 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1) , 804
Open AccessBone morphogenetic protein 10 and one-year outcomes after open revascularisation in symptomatic peripheral arterial disease or carotid stenosis
Background: Bone morphogenetic protein 10 (BMP10) has atrial-specific and vascular properties and may reflect both atrial and vascular pathophysiology. We investigated whether BMP10 levels were associated with new-onset atrial fibrillation (AF), major adverse cardiovascular events (MACE), and all-cause mortality after open revascularisation for symptomatic peripheral arterial disease (PAD) or carotid stenosis (CS). Methods: Patients scheduled for endarterectomy for symptomatic PAD or CS were enrolled. BMP10 concentrations were measured using a multiplex immunoassay. Clinical outcomes were obtained from medical records during one-year follow-up. Associations between BMP10 and outcomes were assessed using Cox proportional hazards regression. Results: A total of 210 patients were included (63% men; 61% underwent surgery for PAD). Women were older than men and had higher BMP10 levels. Forty patients had known preoperative AF. During one-year follow-up, 26 patients experienced MACE and 13 died. Among 170 patients without AF at baseline, 10 developed new-onset AF. In unadjusted Cox regression, higher BMP10 levels were associated with MACE (HR 1.01, 95% CI 1.00-1.03; p = 0.047) and all-cause mortality (HR 1.03, 95% CI 1.01–1.04; p < 0.001), but not with new-onset AF (HR 1.00, 95% CI 0.97–1.03; p = 0.80). Effect estimates were similar after adjustment for age and sex. Model-based point estimates of one-year cumulative incidence were numerically higher at higher BMP10 concentrations for MACE and all-cause mortality, although confidence intervals were wide; no corresponding pattern was observed for new-onset AF. Conclusions: In this exploratory cohort, higher BMP10 levels were associated with MACE and all-cause mortality after endarterectomy for symptomatic PAD or CS. Women had higher BMP10 levels than men. These findings should be interpreted cautiously and considered hypothesis-generating; larger studies are required to validate the observed associations.
- Open Access
- 13 July 2026
- Published by BMJ in Open Heart
- Vol. 13 (2) , e004030
Incidence of post-procedural atrial fibrillation after multivessel percutaneous coronary intervention versus coronary artery bypass grafting: a nationwide observational study
Background: Postoperative atrial fibrillation (AF) is a common complication after coronary artery bypass grafting (CABG) but is less well characterised after multivessel percutaneous coronary intervention (MV-PCI). With the increasing use of MV-PCI, we compared the incidence and clinical implications of clinically significant post-procedural AF following MV-PCI versus CABG. Methods: In this nationwide observational study, we analysed data from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish Prescribed Drug Register. We included all patients in Sweden with chronic coronary syndrome who underwent MV-PCI or isolated CABG between August 2013 and October 2020, excluding those with prior AF or oral anticoagulant (OAC) use in the preceding year. Clinically significant post-procedural AF was defined using a treatment-based proxy: a new OAC dispensation within 3 months after the procedure, with persistence at 9 months. The primary outcome was post-procedural AF incidence at 90 days; secondary outcomes were stroke, myocardial infarction, major bleeding and all-cause mortality. Results: A total of 4471 patients undergoing MV-PCI and 2232 undergoing CABG were included. Post-procedural AF occurred in 0.6% after MV-PCI and 5.7% after CABG (adjusted risk ratio 15.02; 95% CI 8.72 to 25.87; p<0.001). MV-PCI patients were older and had more comorbidities, whereas CABG patients had higher rates of diabetes and more extensive coronary disease. At 90 days, all-cause mortality and major bleeding did not differ significantly. Myocardial infarction was more common after MV-PCI (1.1 vs 0.4%), whereas stroke was more frequent after CABG (0.6 vs 0.3%). Conclusions: Clinically significant post-procedural AF, defined by initiation and persistence of OAC therapy, was nearly tenfold more common after CABG than after MV-PCI. This association remained robust after multivariable adjustment for demographics, comorbidities and angiographic/severity-related factors. Differences in clinical outcomes were modest and should be interpreted cautiously.
- 13 July 2026
- Published by BMJ in Open Heart
- Vol. 13 (2) , e004030
Open AccessIncidence of post-procedural atrial fibrillation after multivessel percutaneous coronary intervention versus coronary artery bypass grafting: a nationwide observational study
Background: Postoperative atrial fibrillation (AF) is a common complication after coronary artery bypass grafting (CABG) but is less well characterised after multivessel percutaneous coronary intervention (MV-PCI). With the increasing use of MV-PCI, we compared the incidence and clinical implications of clinically significant post-procedural AF following MV-PCI versus CABG. Methods: In this nationwide observational study, we analysed data from the Swedish Coronary Angiography and Angioplasty Registry and the Swedish Prescribed Drug Register. We included all patients in Sweden with chronic coronary syndrome who underwent MV-PCI or isolated CABG between August 2013 and October 2020, excluding those with prior AF or oral anticoagulant (OAC) use in the preceding year. Clinically significant post-procedural AF was defined using a treatment-based proxy: a new OAC dispensation within 3 months after the procedure, with persistence at 9 months. The primary outcome was post-procedural AF incidence at 90 days; secondary outcomes were stroke, myocardial infarction, major bleeding and all-cause mortality. Results: A total of 4471 patients undergoing MV-PCI and 2232 undergoing CABG were included. Post-procedural AF occurred in 0.6% after MV-PCI and 5.7% after CABG (adjusted risk ratio 15.02; 95% CI 8.72 to 25.87; p<0.001). MV-PCI patients were older and had more comorbidities, whereas CABG patients had higher rates of diabetes and more extensive coronary disease. At 90 days, all-cause mortality and major bleeding did not differ significantly. Myocardial infarction was more common after MV-PCI (1.1 vs 0.4%), whereas stroke was more frequent after CABG (0.6 vs 0.3%). Conclusions: Clinically significant post-procedural AF, defined by initiation and persistence of OAC therapy, was nearly tenfold more common after CABG than after MV-PCI. This association remained robust after multivariable adjustment for demographics, comorbidities and angiographic/severity-related factors. Differences in clinical outcomes were modest and should be interpreted cautiously.
- Open Access
The Impact of Education Level on the Risk of Heart Failure, Acute Myocardial Infarction, and Stroke in Patients with Atrial Fibrillation - a Swedish Nationwide Cohort Study
Background: Socioeconomic factors impact cardiovascular health. We investigated the association between patient education level and incident heart failure (HF), acute myocardial infarction (AMI), and stroke following a first hospitalization with atrial fibrillation (AF). Methods: In this nationwide retrospective cohort study using linked Swedish national registers, we included all patients receiving a diagnosis of AF while hospitalized in Sweden from 1995 through 2008; categorized education level as primary, secondary, or academic; and followed patients for up to five years. Outcomes were first hospitalization for HF, AMI, or stroke. Associations were assessed using sex-stratified Cox proportional hazards models adjusted for age, calendar year of AF diagnosis, and measures of comorbidity burden (Charlson Comorbidity Index) and thromboembolic risk (CHA2DS2VA score). Results: The cohort comprised 263,172 patients (mean age 72.5 ± 10.4 years; 56.2% male). Compared with primary education, secondary and academic education attainment were associated with lower adjusted risk of HF and AMI in both females and males. For HF, adjusted hazard ratios (HR) were 0.96 (95% CI 0.93 – 1.00) for secondary and 0.82 (95% CI 0.77 – 0.87) for academic education for females and 0.93 (95% CI 0.90 – 0.96) and 0.76 (95% CI 0.72 – 0.80), respectively, for males. For AMI, adjusted HRs were 0.89 (95% CI 0.85 – 0.93) and 0.71 (95% CI 0.65 – 0.78) for females and 0.91 (95% CI 0.87 – 0.94) and 0.75 (95% CI 0.71 – 0.80) for males. For stroke, lower adjusted risk was observed only in the academic education group. Baseline comorbidity burden and thromboembolic risk were higher in lower education groups. Conclusions: Education level was inversely associated with risk of incident HF and AMI over five years, while the association with stroke risk was weaker. Documenting education level may help identify patients at increased risk who could benefit from careful monitoring and optimized preventive care.
Open AccessThe Impact of Education Level on the Risk of Heart Failure, Acute Myocardial Infarction, and Stroke in Patients with Atrial Fibrillation - a Swedish Nationwide Cohort Study
Background: Socioeconomic factors impact cardiovascular health. We investigated the association between patient education level and incident heart failure (HF), acute myocardial infarction (AMI), and stroke following a first hospitalization with atrial fibrillation (AF). Methods: In this nationwide retrospective cohort study using linked Swedish national registers, we included all patients receiving a diagnosis of AF while hospitalized in Sweden from 1995 through 2008; categorized education level as primary, secondary, or academic; and followed patients for up to five years. Outcomes were first hospitalization for HF, AMI, or stroke. Associations were assessed using sex-stratified Cox proportional hazards models adjusted for age, calendar year of AF diagnosis, and measures of comorbidity burden (Charlson Comorbidity Index) and thromboembolic risk (CHA2DS2VA score). Results: The cohort comprised 263,172 patients (mean age 72.5 ± 10.4 years; 56.2% male). Compared with primary education, secondary and academic education attainment were associated with lower adjusted risk of HF and AMI in both females and males. For HF, adjusted hazard ratios (HR) were 0.96 (95% CI 0.93 – 1.00) for secondary and 0.82 (95% CI 0.77 – 0.87) for academic education for females and 0.93 (95% CI 0.90 – 0.96) and 0.76 (95% CI 0.72 – 0.80), respectively, for males. For AMI, adjusted HRs were 0.89 (95% CI 0.85 – 0.93) and 0.71 (95% CI 0.65 – 0.78) for females and 0.91 (95% CI 0.87 – 0.94) and 0.75 (95% CI 0.71 – 0.80) for males. For stroke, lower adjusted risk was observed only in the academic education group. Baseline comorbidity burden and thromboembolic risk were higher in lower education groups. Conclusions: Education level was inversely associated with risk of incident HF and AMI over five years, while the association with stroke risk was weaker. Documenting education level may help identify patients at increased risk who could benefit from careful monitoring and optimized preventive care.
- Open Access
- 25 November 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (21) , 1457-1469
Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study
BACKGROUND: The clinical use of risk scores to guide treatment decisions and improve clinical outcomes has rarely been prospectively evaluated. This study aimed to evaluate whether a biomarker-based ABC-AF risk score–guided multidimensional treatment strategy improves long-term outcomes in patients with AF. METHODS: The multicenter, registry-based, randomized, controlled, open-label study enrolled adults with AF. In the ABC-AF strategy arm, the investigator was informed of each individual’s ABC-AF score risks for stroke and bleeding, which were used as decision support to tailor treatment recommendations, including preference for type of direct oral anticoagulant treatment. In the standard of care arm, patient management was at the discretion of the investigator. Primary outcome was a composite of stroke or death. Secondary outcomes included stroke, death, major bleeding events, and their composite outcome. RESULTS: The intention-to-treat population comprised 3933 patients with a median age of 73.7 years; 33.6% were women, 51.3% had paroxysmal AF, 11.2% had a previous stroke or transient ischemic attack, and 85.7% had oral anticoagulant treatment. After randomization, 97.8% in the ABC-AF strategy arm and 92.6% in the standard of care arm received OACs ( P 2 DS 2 -VASc scores of ≥3, and the study was therefore underpowered for its primary objective. Over a median follow-up of 2.6 years, 175 primary events (3.18/100 patient-years [100PY]) occurred in the ABC-AF strategy and 148 (2.67/100PY) in the standard of care arm (hazard ratio [HR], 1.19 [95% CI, 0.96–1.48]; P =0.12). Major bleeding events were 152 (2.82/100PY) versus 141 (2.61/100PY; HR, 1.08 [95% CI, 0.86–1.36]; P =0.50), stroke 48 (0.87/100PY) versus 41 (0.74/100PY; HR, 1.18 [95% CI, 0.78–1.79]; P =0.44), death 136 (2.44/100PY) versus 113 (2.02/100PY; HR, 1.21 [95% CI, 0.94–1.55]; P =0.13), and rates of composite stroke, death, or major bleeding 277 (5.21/100PY) versus 244 (4.55/100PY; HR, 1.14 [95% CI, 0.96–1.36]; P =0.13). Primary outcome results were similar across ABC-AF score subgroups (interaction P =0.98). CONCLUSIONS: The individually tailored multidimensional treatment strategy, based on ABC-AF risk scores, did not improve clinical outcomes compared with usual guideline-based care in patients with AF. The results emphasize the need for prospective testing of the use of risk stratification and precision medicine tools in different clinical settings before implementation in routine care. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03753490.
- 25 November 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (21) , 1457-1469
Open AccessBiomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study
BACKGROUND: The clinical use of risk scores to guide treatment decisions and improve clinical outcomes has rarely been prospectively evaluated. This study aimed to evaluate whether a biomarker-based ABC-AF risk score–guided multidimensional treatment strategy improves long-term outcomes in patients with AF. METHODS: The multicenter, registry-based, randomized, controlled, open-label study enrolled adults with AF. In the ABC-AF strategy arm, the investigator was informed of each individual’s ABC-AF score risks for stroke and bleeding, which were used as decision support to tailor treatment recommendations, including preference for type of direct oral anticoagulant treatment. In the standard of care arm, patient management was at the discretion of the investigator. Primary outcome was a composite of stroke or death. Secondary outcomes included stroke, death, major bleeding events, and their composite outcome. RESULTS: The intention-to-treat population comprised 3933 patients with a median age of 73.7 years; 33.6% were women, 51.3% had paroxysmal AF, 11.2% had a previous stroke or transient ischemic attack, and 85.7% had oral anticoagulant treatment. After randomization, 97.8% in the ABC-AF strategy arm and 92.6% in the standard of care arm received OACs ( P 2 DS 2 -VASc scores of ≥3, and the study was therefore underpowered for its primary objective. Over a median follow-up of 2.6 years, 175 primary events (3.18/100 patient-years [100PY]) occurred in the ABC-AF strategy and 148 (2.67/100PY) in the standard of care arm (hazard ratio [HR], 1.19 [95% CI, 0.96–1.48]; P =0.12). Major bleeding events were 152 (2.82/100PY) versus 141 (2.61/100PY; HR, 1.08 [95% CI, 0.86–1.36]; P =0.50), stroke 48 (0.87/100PY) versus 41 (0.74/100PY; HR, 1.18 [95% CI, 0.78–1.79]; P =0.44), death 136 (2.44/100PY) versus 113 (2.02/100PY; HR, 1.21 [95% CI, 0.94–1.55]; P =0.13), and rates of composite stroke, death, or major bleeding 277 (5.21/100PY) versus 244 (4.55/100PY; HR, 1.14 [95% CI, 0.96–1.36]; P =0.13). Primary outcome results were similar across ABC-AF score subgroups (interaction P =0.98). CONCLUSIONS: The individually tailored multidimensional treatment strategy, based on ABC-AF risk scores, did not improve clinical outcomes compared with usual guideline-based care in patients with AF. The results emphasize the need for prospective testing of the use of risk stratification and precision medicine tools in different clinical settings before implementation in routine care. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03753490.
- Open Access
- 29 August 2025
- Published by Wiley in Physiological Reports
- Vol. 13 (17) , e70531
Seasonal variations in ventricular repolarization and tachyarrhythmias in hibernating brown bears (Ursus arctos arctos)
In humans, hypothermia prolongs ventricular repolarization and associates with sustained ventricular tachyarrhythmias. In bears, body temperature drops during hibernation similar to moderate human hypothermia, yet they rarely face fatal outcomes during the winter. This suggests protective adaptations in bear electrophysiology. We studied seasonality in ursine ventricular repolarization by analyzing >1 year electrocardiogram (ECG) recordings from loop recorders implanted in 57 free‐ranging Eurasian brown bears. In sinus rhythm, bears exhibited significantly longer RR, QT, and Tpeak‐Tend intervals (2441 ± 470, 508 ± 50, and 53 ± 8 ms, respectively) during hibernation than in the active period (649 ± 323, 232 ± 39, and 29 ± 5 ms, respectively). Optimal heart rate correction of QT interval (QT/RR0.435) demonstrated significant prolongation during hibernation. QT and Tpeak‐Tend intervals remained longer during hibernation than in the active period, even when comparing ECGs with similar RR intervals in the two periods. Ventricular fibrillation occurred in four bears shot during licensed hunting in summer, which led to death. In conclusion, seasonal variations in ventricular repolarization in bears appear, at least partially, independently of heart rate. Compared to humans, ventricular repolarization is slower but more homogeneous. These findings, combined with the absence of fatalities during hibernation, support the theory of protective electrophysiological adaptations in bears. Insights into the underlying mechanisms have biomimetic potential for human therapy.
- 29 August 2025
- Published by Wiley in Physiological Reports
- Vol. 13 (17) , e70531
Open AccessSeasonal variations in ventricular repolarization and tachyarrhythmias in hibernating brown bears (Ursus arctos arctos)
In humans, hypothermia prolongs ventricular repolarization and associates with sustained ventricular tachyarrhythmias. In bears, body temperature drops during hibernation similar to moderate human hypothermia, yet they rarely face fatal outcomes during the winter. This suggests protective adaptations in bear electrophysiology. We studied seasonality in ursine ventricular repolarization by analyzing >1 year electrocardiogram (ECG) recordings from loop recorders implanted in 57 free‐ranging Eurasian brown bears. In sinus rhythm, bears exhibited significantly longer RR, QT, and Tpeak‐Tend intervals (2441 ± 470, 508 ± 50, and 53 ± 8 ms, respectively) during hibernation than in the active period (649 ± 323, 232 ± 39, and 29 ± 5 ms, respectively). Optimal heart rate correction of QT interval (QT/RR0.435) demonstrated significant prolongation during hibernation. QT and Tpeak‐Tend intervals remained longer during hibernation than in the active period, even when comparing ECGs with similar RR intervals in the two periods. Ventricular fibrillation occurred in four bears shot during licensed hunting in summer, which led to death. In conclusion, seasonal variations in ventricular repolarization in bears appear, at least partially, independently of heart rate. Compared to humans, ventricular repolarization is slower but more homogeneous. These findings, combined with the absence of fatalities during hibernation, support the theory of protective electrophysiological adaptations in bears. Insights into the underlying mechanisms have biomimetic potential for human therapy.
- Open Access
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional study
Objectives: To establish the prevalence of clinically significant chronic obstructive pulmonary disease (COPD) and relevant characteristics in individuals with a significant smoking history who are hospitalised for acute myocardial infarction (MI). Design: Cross-sectional study. Setting: Hospital inpatients at 8 European centres (7 in Sweden, 1 in the UK). Participants: 518 men or women (302 in Sweden, 216 in the UK) hospitalised for acute MI, aged 40 years or older, with a smoking history of at least 10 pack-years. Primary and secondary outcome measures: The primary outcome was prevalence of detected significant COPD (Global Initiative for Chronic Obstructive Lung Disease stages 2–4), defined as a ratio of forced expiratory volume in 1 and 6 s (FEV 1 /FEV 6 ) 1 10 was found in 65%, and a blood eosinophil count of ≥100/mm 3 and ≥300/mm 3 was found in 76% and 20%, respectively. Inhaled corticosteroids were used by 15% of the patients. Conclusions: In a cohort of patients hospitalised for acute MI in Sweden and the UK, one in five patients with a history of smoking was found to have significant COPD based on microspirometry. Symptom burden was high and treatment rates with ICS low. Among those diagnosed with COPD, three out of four had not been previously diagnosed with COPD.
Open AccessPrevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional study
Objectives: To establish the prevalence of clinically significant chronic obstructive pulmonary disease (COPD) and relevant characteristics in individuals with a significant smoking history who are hospitalised for acute myocardial infarction (MI). Design: Cross-sectional study. Setting: Hospital inpatients at 8 European centres (7 in Sweden, 1 in the UK). Participants: 518 men or women (302 in Sweden, 216 in the UK) hospitalised for acute MI, aged 40 years or older, with a smoking history of at least 10 pack-years. Primary and secondary outcome measures: The primary outcome was prevalence of detected significant COPD (Global Initiative for Chronic Obstructive Lung Disease stages 2–4), defined as a ratio of forced expiratory volume in 1 and 6 s (FEV 1 /FEV 6 ) 1 10 was found in 65%, and a blood eosinophil count of ≥100/mm 3 and ≥300/mm 3 was found in 76% and 20%, respectively. Inhaled corticosteroids were used by 15% of the patients. Conclusions: In a cohort of patients hospitalised for acute MI in Sweden and the UK, one in five patients with a history of smoking was found to have significant COPD based on microspirometry. Symptom burden was high and treatment rates with ICS low. Among those diagnosed with COPD, three out of four had not been previously diagnosed with COPD.
- Open Access
- 15 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Biomarkers of inflammation in sweat after myocardial infarction
ST-elevation myocardial infarction (STEMI) triggers a significant inflammatory response. Sweat may offer a novel, non-invasive medium for monitoring inflammation. In this prospective study, we characterized the inflammatory signatures in plasma and sweat collected from the skin surface of two patient groups: (1) 18 STEMI patients immediately following percutaneous coronary intervention (exposure) and (2) six patients who underwent outpatient angiography without subsequent intervention (control). Levels of 92 biomarkers were measured using a high-throughput proteomic assay and reassessed after 4–6 weeks in STEMI patients. Adjusting for patient group, sweat biomarkers did not show significant changes over time. In plasma, hepatocyte growth factor and interleukin-6 showed a significant decrease from the acute phase to follow-up, adjusted for patient group. STAM binding protein was significantly higher in the sweat of STEMI patients compared to controls, adjusted for time effects. While sweat was less sensitive than plasma for detecting biomarker levels in the setting of STEMI, its longitudinal analysis via wearable sensors holds promise for detecting specific markers. Trial registration: The trial is registered on www.clinicaltrials.gov with the trial registration number NCT05843006.
- 15 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessBiomarkers of inflammation in sweat after myocardial infarction
ST-elevation myocardial infarction (STEMI) triggers a significant inflammatory response. Sweat may offer a novel, non-invasive medium for monitoring inflammation. In this prospective study, we characterized the inflammatory signatures in plasma and sweat collected from the skin surface of two patient groups: (1) 18 STEMI patients immediately following percutaneous coronary intervention (exposure) and (2) six patients who underwent outpatient angiography without subsequent intervention (control). Levels of 92 biomarkers were measured using a high-throughput proteomic assay and reassessed after 4–6 weeks in STEMI patients. Adjusting for patient group, sweat biomarkers did not show significant changes over time. In plasma, hepatocyte growth factor and interleukin-6 showed a significant decrease from the acute phase to follow-up, adjusted for patient group. STAM binding protein was significantly higher in the sweat of STEMI patients compared to controls, adjusted for time effects. While sweat was less sensitive than plasma for detecting biomarker levels in the setting of STEMI, its longitudinal analysis via wearable sensors holds promise for detecting specific markers. Trial registration: The trial is registered on www.clinicaltrials.gov with the trial registration number NCT05843006.
- Open Access
- 7 February 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (2) , e258314
Right ventricular lead perforation with iatrogenic injury to an intercostal artery causing haemothorax after pacemaker implant
A woman in her 80s experienced a life-threatening complication of pacemaker implant consisting of subacute right ventricular lead perforation causing iatrogenic injury to an intercostal artery, resulting in a large haemothorax. A CT scan confirmed active bleeding from the fourth intercostal artery. The patient underwent cardiothoracic surgery via a median sternotomy approach, during which the source of the bleeding was sealed, a new epicardial lead was positioned, and the original lead was extracted. This case emphasises the potentially severe consequences of pacemaker lead perforation and secondary injury to adjacent structures. It underscores the importance of early recognition and timely intervention, preferably in a tertiary specialist unit equipped for cardiothoracic surgery and confirms the value of pacemaker interrogation and CT scans for diagnosis.
- 7 February 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (2) , e258314
Open AccessRight ventricular lead perforation with iatrogenic injury to an intercostal artery causing haemothorax after pacemaker implant
A woman in her 80s experienced a life-threatening complication of pacemaker implant consisting of subacute right ventricular lead perforation causing iatrogenic injury to an intercostal artery, resulting in a large haemothorax. A CT scan confirmed active bleeding from the fourth intercostal artery. The patient underwent cardiothoracic surgery via a median sternotomy approach, during which the source of the bleeding was sealed, a new epicardial lead was positioned, and the original lead was extracted. This case emphasises the potentially severe consequences of pacemaker lead perforation and secondary injury to adjacent structures. It underscores the importance of early recognition and timely intervention, preferably in a tertiary specialist unit equipped for cardiothoracic surgery and confirms the value of pacemaker interrogation and CT scans for diagnosis.
- Open Access
- 24 May 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 46 (7) , 782-787
Validation of a handheld single‐lead ECG algorithm for atrial fibrillation detection after coronary revascularization
BackgroundAtrial fibrillation (AF) is a rapidly increasing global public health concern entailing a high risk for ischemic stroke that can largely be avoided with anticoagulation therapy. AF is often underdiagnosed and there is a need for a reliable method of detection in individuals with additional risk factors for stroke such as coronary artery disease. We aimed to validate an automatic rhythm interpretation algorithm in thumb ECG in subjects with recent coronary revascularization. MethodsThumb ECG, a patient-operated handheld single-lead ECG recording device with an automatic interpretation algorithm, was performed three times daily for a month after coronary revascularization and 2-week periods 3, 12, and 24 months post-procedure. The detection of AF by the automatic algorithm on subject and single-strip ECG level was compared to manual interpretation. Results48,308 of 30 s thumb ECG recordings from 255 subjects (mean 212 +/- 3.5 recordings per subject) were retrieved from a database (AF 47 subjects/655 recordings; non-AF 208 subjects/47,653 recordings). The algorithm sensitivity at subject level was 100%, specificity 11.2%, positive predictive value (PPV) 20.2%, and negative predictive value (NPV) 100%. At the single-strip ECG level, sensitivity was 87.6%, specificity 94.0%, PPV 16.8%, and NPV 99.8%. The most common reasons for false positive results were technical disturbance and frequent ectopic beats. ConclusionsThe automatic interpretation algorithm in a handheld thumb ECG device can rule out AF in patients recently undergoing coronary revascularization with high accuracy, but manual confirmation is needed to confirm the diagnose of AF because of high false positive rates.
- 24 May 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 46 (7) , 782-787
Open AccessValidation of a handheld single‐lead ECG algorithm for atrial fibrillation detection after coronary revascularization
BackgroundAtrial fibrillation (AF) is a rapidly increasing global public health concern entailing a high risk for ischemic stroke that can largely be avoided with anticoagulation therapy. AF is often underdiagnosed and there is a need for a reliable method of detection in individuals with additional risk factors for stroke such as coronary artery disease. We aimed to validate an automatic rhythm interpretation algorithm in thumb ECG in subjects with recent coronary revascularization. MethodsThumb ECG, a patient-operated handheld single-lead ECG recording device with an automatic interpretation algorithm, was performed three times daily for a month after coronary revascularization and 2-week periods 3, 12, and 24 months post-procedure. The detection of AF by the automatic algorithm on subject and single-strip ECG level was compared to manual interpretation. Results48,308 of 30 s thumb ECG recordings from 255 subjects (mean 212 +/- 3.5 recordings per subject) were retrieved from a database (AF 47 subjects/655 recordings; non-AF 208 subjects/47,653 recordings). The algorithm sensitivity at subject level was 100%, specificity 11.2%, positive predictive value (PPV) 20.2%, and negative predictive value (NPV) 100%. At the single-strip ECG level, sensitivity was 87.6%, specificity 94.0%, PPV 16.8%, and NPV 99.8%. The most common reasons for false positive results were technical disturbance and frequent ectopic beats. ConclusionsThe automatic interpretation algorithm in a handheld thumb ECG device can rule out AF in patients recently undergoing coronary revascularization with high accuracy, but manual confirmation is needed to confirm the diagnose of AF because of high false positive rates.
- Open Access
- 16 December 2022
- Published by Elsevier in Heart Rhythm O2
- Vol. 3 (6) , 766-770
Catheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities
- 16 December 2022
- Published by Elsevier in Heart Rhythm O2
- Vol. 3 (6) , 766-770
Open AccessCatheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities